Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemoglobin Beta Thalassemia”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Not applicableStudy completedNCT04678037
What this trial is testing

Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study

Who this might be right for
Sickle Cell DiseaseSickle Cell Hemoglobin CSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 40
Testing effectiveness (Phase 2)Study completedNCT03763656
What this trial is testing

Pharmacokinetics of Oral Hydroxyurea Solution

Who this might be right for
Sickle Cell DiseaseSickle-Cell; Hemoglobin Disease, ThalassemiaSickle Cell-beta-thalassemia+1 more
Nova Laboratories Limited 33
Testing effectiveness (Phase 2)Study completedNCT01609595
What this trial is testing

Study of SDMB (2,2 Dimethylbutyrate, Sodium Salt) in Beta Thalassemia Intermedia in Thailand

Who this might be right for
Beta Thalassemia Intermedia
Boston University 10
Not applicableLooking for participantsNCT04688411
What this trial is testing

An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Beta Zero ThalassemiaSickle B+ Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 40
Testing effectiveness (Phase 2)UnknownNCT03276455
What this trial is testing

Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified

Who this might be right for
Beta Thalassemia Major
Nanfang Hospital, Southern Medical University 10
Not applicableActive Not RecruitingNCT04691323
What this trial is testing

The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.

Who this might be right for
Sickle Cell DiseaseSickle B+ ThalassemiaSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 68
Testing effectiveness (Phase 2)Study completedNCT06239389
What this trial is testing

Comparison Of Efficacy And Safety Of Thalidomide Vs Hydroxyurea In Thalassemia Patients: A Single-Centre Pilot Study.

Who this might be right for
Beta-Thalassemia
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 24
Testing effectiveness (Phase 2)Study completedNCT00790127
What this trial is testing

Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia

Who this might be right for
Beta Thalassemia
HemaQuest Pharmaceuticals Inc. 21
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+19 more
Masonic Cancer Center, University of Minnesota 70
Testing effectiveness (Phase 2)UnknownNCT04247750
What this trial is testing

Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients (THALA-RAP)

Who this might be right for
Beta-Thalassemia
Università degli Studi di Ferrara 45
Early research (Phase 1)Study completedNCT02998450
What this trial is testing

IMR-687 in Healthy Adult Volunteers

Who this might be right for
Sickle Cell DiseaseSickle-Cell; Hb-SCSickle Beta 0 Thalassemia
Cardurion Pharmaceuticals, Inc. 66
Testing effectiveness (Phase 2)Study completedNCT00153985
What this trial is testing

Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

Who this might be right for
HemoglobinopathiesSickle Cell DiseaseThalassemia
Dana-Farber Cancer Institute 2
Not applicableStudy completedNCT02197845
What this trial is testing

Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators

Who this might be right for
Sickle Cell Disease
Virginia Commonwealth University 353
Not applicableStudy completedNCT06831799
What this trial is testing

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

Who this might be right for
HemoglobinopathiesSickle Cell DiseaseSickle Cell Anemia+21 more
Hospital Universitari Vall d'Hebron Research Institute 684
Not applicableStudy completedNCT03764813
What this trial is testing

Cord Blood Transfusion In Preterm Neonates (CB-TrIP)

Who this might be right for
Premature Infant DiseaseTransfusion Related ComplicationFetal Hemoglobin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 25
Large-scale testing (Phase 3)UnknownNCT04191213
What this trial is testing

Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients

Who this might be right for
Sickle Cell Anemia in Children
Al-Neelain University 100
Testing effectiveness (Phase 2)Study completedNCT03877809
What this trial is testing

Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients

Who this might be right for
Beta-Thalassemia
Rare Partners srl Impresa Sociale 26
Early research (Phase 1)Study completedNCT01522547
What this trial is testing

Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell Disease

Who this might be right for
Anemia, Sickle Cell
Celgene 12
Testing effectiveness (Phase 2)Ended earlyNCT00034528
What this trial is testing

Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia

Who this might be right for
HemoglobinopathiesAnemia, Sickle CellHemoglobin SC Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 2
Not applicableStudy completedNCT04675645
What this trial is testing

Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App

Who this might be right for
Sickle Cell DiseaseSickle B+ ThalassemiaSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 33
Load More Results